Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV-infected people on opioid agonist therapy.
Macías J, Téllez F, de Los Santos I, Morano LE, Merino D, Granados R, Vera-Mendez F, González-Serna A, Campo-Moneo E, García-Fraile L, García F, Real LM, Pineda JA; RIS-HEP20 Study and the HEPAVIR and GEHEP Study Groups.
Macías J, et al. Among authors: pineda ja.
J Viral Hepat. 2021 Jun;28(6):878-886. doi: 10.1111/jvh.13496. Epub 2021 Apr 15.
J Viral Hepat. 2021.
PMID: 33721377